-
Product Insights
New5-Hydroxytryptamine Receptor 2A – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 2A pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 2A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Immunology, and Genetic Disorders which include indications of Schizophrenia, Unspecified Psychiatric Disorders, Obesity, Metabolic Disorders, Inflammation, Psoriasis, Fragile X Syndrome, and Prader-Willi Syndrome (PWS). It also reviews...
-
Product Insights
NewMu Type Opioid Receptor – Drugs In Development, 2024
The Mu Type Opioid Receptor pipeline drugs market research report outlays comprehensive information on the Mu Type Opioid Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Toxicology, Gastrointestinal, and Dermatology which include indications of Pain, Opium (Opioid) Addiction, Acute Opioid Overdosage, Opioid Induced Side Effects, Irritable Bowel Syndrome, Nausea , Pruritus, and Uremic...
-
Product Insights
NewGTPase KRas – Drugs In Development, 2024
The GTPase KRas pipeline drugs market research report outlays comprehensive information on the GTPase KRas targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Undisclosed, Infectious Disease, and Immunology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Unspecified, Epstein–Barr Virus (HHV-4) Infections, and Unspecified Immunological Disorders. It also reviews key players involved in GTPase KRas...
-
Product Insights
NewReceptor Tyrosine Protein Kinase ERBB 2 – Drugs In Development, 2024
The Receptor Tyrosine Protein Kinase ERBB 2 pipeline drugs market research report outlays comprehensive information on the Receptor Tyrosine Protein Kinase ERBB 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Women's Health, Other Diseases, and Hematological Disorders which include indications of Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Breast Cancer,...
-
Product Insights
NewVascular Endothelial Growth Factor A – Drugs In Development, 2024
The Vascular Endothelial Growth Factor A pipeline drugs market research report outlays comprehensive information on the Vascular Endothelial Growth Factor A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, Metabolic Disorders, and Cardiovascular which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Non-Proliferative Diabetic...
-
Product Insights
NewProstaglandin G/H Synthase 2 – Drugs In Development, 2024
The Prostaglandin G/H Synthase 2 pipeline drugs market research report outlays comprehensive information on the Prostaglandin G/H Synthase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Musculoskeletal Disorders, and Oncology which include indications of Pain, Post-Operative Pain, Inflammation, Rheumatoid Arthritis, Osteoarthritis, Muscle Spasm, Solid Tumor, and Non-Small Cell Lung Cancer. It also...
-
Product Insights
NewGlucocorticoid Receptor – Drugs In Development, 2024
The Glucocorticoid Receptor pipeline drugs market research report outlays comprehensive information on the Glucocorticoid Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Ophthalmology, Central Nervous System, and Immunology which include indications of Asthma, Chronic Obstructive Pulmonary Disease (COPD), Ocular Inflammation, Diabetic Macular Edema, Ocular Pain (Eye Pain), Osteoarthritis Pain, Inflammation, and Plaque Psoriasis (Psoriasis Vulgaris)....
-
Product Insights
New5-Hydroxytryptamine Receptor 1 – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 1 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Cardiovascular, and Oncology which include indications of Schizophrenia, Migraine, Inflammation, Psoriasis, Pulmonary Arterial Hypertension, Stroke, Breast Cancer, and Melanoma. It also reviews key players involved in 5-Hydroxytryptamine Receptor...
-
Product Insights
NewTumor Necrosis Factor Receptor Superfamily Member 9 – Drugs In Development, 2024
The Tumor Necrosis Factor Receptor Superfamily Member 9 pipeline drugs market research report outlays comprehensive information on the Tumor Necrosis Factor Receptor Superfamily Member 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Immunology, and Hematological Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Coronavirus Disease 2019 (COVID-19), Autoimmune Disorders, and...
-
Product Insights
NewLeukocyte Surface Antigen CD47 – Drugs In Development, 2024
The Leukocyte Surface Antigen CD47 pipeline drugs market research report outlays comprehensive information on the Leukocyte Surface Antigen CD47 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, Hematological Disorders, and Dermatology which include indications of Solid Tumor, Lymphoma, Diabetic Retinopathy, Sickle Cell Disease, Thalassemia, and Pyoderma Gangrenosum. It also reviews key players involved in Leukocyte...